| Line Item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Profit or loss [abstract] | ||||||
| Revenues | ||||||
| Cost of revenues | ||||||
| Inventory impairment loss | ||||||
| Gross (loss) profit | ||||||
| Research and development expenses, net | ||||||
| Selling and marketing expenses, net | ||||||
| General and administrative expenses | ||||||
| Operating loss | ||||||
| Financing expenses | ||||||
| Financing income | ||||||
| Financing income (expenses), net | ||||||
| Loss for the year | ||||||
| Comprehensive loss for the year | ||||||
| Basic and diluted loss per share: | ||||||
| Basic loss per share (in New Shekels per share) | ||||||
| Diluted loss per share (in New Shekels per share) |